Latest stories on OKUR
OnKure Therapeutics GAAP EPS of -$0.36
Seeking Alpha38 · neutralearnings
OnKure Therapeutics reports Q3 EPS (36c), consensus (41c)
The Fly61 · neutralearnings
OnKure Therapeutics, Inc. (OKUR) files 8-K
SEC 8-K50 · neutralgeneral
OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
GlobeNewswire52 · neutralearnings
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
Business Insider56 · neutralgeneral
OnKure Therapeutics price target lowered to $14 from $30 at Oppenheimer
The Fly34 · bearishanalyst
OnKure Therapeutics, Inc. (OKUR) files 8-K
SEC 8-K50 · neutralgeneral
OKUR Options Data Summary for Onkure Therapeutics Inc
Barchart50 · neutralgeneral
OnKure Therapeutics, Inc. (OKUR) files 8-K
SEC 8-K50 · neutralgeneral
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
StockTitan38 · neutralearnings
H.C. Wainwright cuts OnKure stock price target to $21 on valuation changes
Investing.com Analyst Ratings34 · bearishanalyst